Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × copanlisib × Clear all

NCT02455297 2017-10-02

Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Phase 2 Terminated

Lymphoma, Mantle-Cell